within Pharmacolibrary.Drugs.ATC.R;

model R06AX11
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.6,
    Cl             = 2.5e-05,
    adminDuration  = 600,
    adminMass      = 30 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.06,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0007,
    Tlag           = 600,            
    Vdp             = 0.03,
    k12             = 0.98,
    k21             = 0.98
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>R06AX11</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Astemizole is a long-acting, non-sedating antihistamine (H1-receptor antagonist) that was formerly used for the treatment of allergic conditions such as rhinitis and urticaria. Due to safety concerns, notably serious cardiac arrhythmias (QT prolongation, torsades de pointes), astemizole has been withdrawn from the market in many countries and is generally not approved for use today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics in healthy adult volunteers following single oral dose.</p><h4>References</h4><ol><li><p>Bailey, DG, et al., &amp; Spence, JD (1998). Grapefruit juice-drug interactions. <i>British journal of clinical pharmacology</i> 46(2) 101–110. DOI:<a href=\"https://doi.org/10.1046/j.1365-2125.1998.00764.x\">10.1046/j.1365-2125.1998.00764.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/9723817/\">https://pubmed.ncbi.nlm.nih.gov/9723817</a></p></li><li><p>Mann, KV, et al., &amp; Tietze, KJ (1989). Nonsedating histamine H1-receptor antagonists. <i>Clinical pharmacy</i> 8(5) 331–344. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2568212/\">https://pubmed.ncbi.nlm.nih.gov/2568212</a></p></li><li><p>Leyden, J (1998). Pharmacokinetics and pharmacology of terbinafine and itraconazole. <i>Journal of the American Academy of Dermatology</i> 38(5 Pt 3) S42–S47. DOI:<a href=\"https://doi.org/10.1016/s0190-9622(98)70483-9\">10.1016/s0190-9622(98)70483-9</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/9594936/\">https://pubmed.ncbi.nlm.nih.gov/9594936</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end R06AX11;
